Monday, December 23, 2024
HomeTagsIIBR

IIBR

NRx Announces Publication of Initial Findings of BriLife® Vaccine-produced Antibodies Against Omicron Variant –

NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics